NVO · Healthcare
Novo-Nordisk A S
46/100
Smart-money confidence1 of 3 sources positive
Above average interest
No standout activity across the feeds we track.
What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Hedge funds
61
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$171.4B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About NOVO-NORDISK A S
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin…
Who's behind the signal
Every informed buyer we can see on NVO, across all three feeds.
Hedge funds · 12
Gotham Asset Mgmt (Greenblatt)
New position
Point72 (Steve Cohen)
New position
Dodge & Cox
Increased +6%
Millennium Management (Englander)
Increased +44%
AQR Capital Management
Increased +79%
Markel Group (Tom Gayner)
Unchanged
+6 more in the full breakdown below ↓
Congress · 13
Alan Armstrong
bought
Lisa C. McClain
sold
Marjorie Taylor Greene
bought
Scott Franklin
bought
Laurel M. Lee
sold
Byron Donalds
sold
Val T. Hoyle
bought
John James
sold
+5 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 28 on record
Disclosures from 2017-09-08 to 2026-03-30
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-03-30 | Alan Armstrong · R-OK | Senate | Bought | $15,001 - $50,000 |
| 2025-10-31 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-10-15 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-09-11 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-08-28 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-08-19 | Marjorie Taylor Greene · R-GA | House | Bought | $15,001 - $50,000 |
| 2025-08-04 | Scott Franklin · R-FL | House | Bought | $15,001 - $50,000 |
| 2025-08-04 | Scott Franklin · R-FL | House | Bought | $1,001 - $15,000 |
Show the other 18
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-08-04 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-07-10 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-06-09 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-05-08 | Laurel M. Lee · R-FL | House | Sold | $1,001 - $15,000 |
| 2025-03-27 | Scott Franklin · R-FL | House | Bought | $1,001 - $15,000 |
| 2025-03-27 | Scott Franklin · R-FL | House | Bought | $15,001 - $50,000 |
| 2025-03-20 | Byron Donalds · R-FL | House | Sold | $1,001 - $15,000 |
| 2024-10-29 | Val T. Hoyle · D-OR | House | Bought | $1,001 - $15,000 |
| 2024-09-04 | John James · R-MI | House | Sold | $1,001 - $15,000 |
| 2023-11-10 | John James · R-MI | House | Bought | $1,001 - $15,000 |
| 2023-07-12 | Daniel S. Goldman · D-NY | House | Sold | $100,001+ |
| 2023-07-10 | Daniel S. Goldman · D-NY | House | Sold | $250,001 - $500,000 |
| 2021-09-16 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2020-11-05 | Katherine M. Clark · D-MA | House | Bought | $1,001 - $15,000 |
| 2020-04-02 | Thomas R. Carper · D-DE | Senate | Bought | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
| 2019-03-11 | Shelley Moore Capito · R-WV | Senate | Sold | $1,001 - $15,000 |
| 2017-09-08 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
NOVO-NORDISK A S isn't in the top-10 model right now, but 12 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
12
Investors
2
New positions
3
Increasing
5
Decreasing
2
Unchanged
Price History
Loading price data...
A member of Congress bought
A member sold
Return:
High:
Low:
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.0%
Position change
NEW
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.2×
% of portfolio
0.5%
Position change
+6%
0.5% of Dodge & Cox's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+44%
0.1% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+79%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.4×
% of portfolio
1.1%
Position change
—
1.1% of Markel Group's portfolio
Trust weight: 1.2×
% of portfolio
0.7%
Position change
−20%
0.7% of Maverick Capital's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
−11%
0.2% of Renaissance Technologies's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
−59%
0.0% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−50%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−66%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.4×
% of portfolio
0.0%
Position change
—
0.0% of Baillie Gifford & Co's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to NOVO-NORDISK A S
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell NOVO-NORDISK A S or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime